Related references
Note: Only part of the references are listed.Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration
Jurgen Kruecken et al.
PLOS PATHOGENS (2021)
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
Linda Batsa Debrah et al.
CLINICAL INFECTIOUS DISEASES (2020)
Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro
Marc P. Huebner et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis
Mark J. Taylor et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity
Thomas W. von Geldern et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Wolbachia endosymbionts subvert the endoplasmic reticulum to acquire host membranes without triggering ER stress
Nour Fattouh et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae
Marc P. Huebner et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis
W. David Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Using synthetic oligonucleotides as standards in probe-based qPCR
Jillian Conte et al.
BIOTECHNIQUES (2018)
Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model
Sabine Specht et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial
Ute Klarmann-Schulz et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial
Alexander Yaw Debrah et al.
CLINICAL INFECTIOUS DISEASES (2015)
Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
Hugo C. Turner et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Efficient in vitro RNA interference and immunofluorescence-based phenotype analysis in a human parasitic nematode, Brugia malayi
Frederic Landmann et al.
PARASITES & VECTORS (2012)
A Cell-Based Screen Reveals that the Albendazole Metabolite, Albendazole Sulfone, Targets Wolbachia
Laura R. Serbus et al.
PLOS PATHOGENS (2012)
Quantification Bias Caused by Plasmid DNA Conformation in Quantitative Real-Time PCR Assay
Chih-Hui Lin et al.
PLOS ONE (2011)
Serious Overestimation in Quantitative PCR by Circular (Supercoiled) Plasmid Standard: Microalgal pcna as the Model Gene
Yubo Hou et al.
PLOS ONE (2010)
Newly acquired Onchocerca volvulus filariae after doxycycline treatment
Sabine Specht et al.
PARASITOLOGY RESEARCH (2009)
Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis:: a randomized placebo-controlled study
Achim Hoerauf et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2008)
A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection
JD Turner et al.
CLINICAL INFECTIOUS DISEASES (2006)
Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment
A Hoerauf et al.
LANCET (2001)
Share Paper
